{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:08:05Z","timestamp":1793869685283,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515220028, and 2025A1515012054"],"award-info":[{"award-number":["2024A1515220028, and 2025A1515012054"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515030272"],"award-info":[{"award-number":["2023A1515030272"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Li Ka Shing Foundation STU-GTIIT Joint-Research Grant","award":["2024LKSFG03"],"award-info":[{"award-number":["2024LKSFG03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04027-8","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:25:27Z","timestamp":1768577127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Low-dose X-ray-activated radiodynamic therapy via a lutetium-coordinated nanoplatform synergizing PARP inhibition and ferroptosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Wanli","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqing","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingpeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"1","key":"4027_CR1","first-page":"34","volume":"72","author":"WA Hall","year":"2022","unstructured":"Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, et al. Magnetic resonance linear accelerator technology and adaptive radiation therapy: an overview for clinicians. CA Cancer J Clin. 2022;72(1):34\u201356.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4027_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41577-021-00568-1","volume":"22","author":"UM Cytlak","year":"2022","unstructured":"Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol. 2022;22(2):124\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4027_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s12276-021-00640-9","volume":"53","author":"T Suwa","year":"2021","unstructured":"Suwa T, Kobayashi M, Nam JM, Harada H. Tumor microenvironment and radioresistance. Exp Mol Med. 2021;53(6):1029\u201335.","journal-title":"Exp Mol Med"},{"issue":"1","key":"4027_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12951-025-03264-7","volume":"23","author":"D Yao","year":"2025","unstructured":"Yao D, Wang Y, Dong X, Chen Y, Ji D, Zou R, et al. Renal-clearable and tumor-retained nanodots overcoming metabolic reprogramming to boost mitochondrial-targeted photodynamic therapy in triple-negative breast cancer. J Nanobiotechnol. 2025;23(1):195.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4027_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12951-024-02931-5","volume":"22","author":"A Mushtaq","year":"2024","unstructured":"Mushtaq A, Iqbal MZ, Tang J, Sun W. The wonders of X-PDT: an advance route to cancer theranostics. J Nanobiotechnol. 2024;22(1):655.","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"4027_CR6","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.1021\/acs.nanolett.9b03682","volume":"19","author":"X Zhong","year":"2019","unstructured":"Zhong X, Wang X, Zhan G, Tang Y, Yao Y, Dong Z, et al. NaCeF4: Gd, Tb scintillator as an X-ray responsive photosensitizer for multimodal imaging-guided synchronous radio\/radiodynamic therapy. Nano Lett. 2019;19(11):8234\u201344.","journal-title":"Nano Lett"},{"issue":"12","key":"4027_CR7","doi-asserted-by":"publisher","first-page":"19691","DOI":"10.1021\/acsnano.2c07286","volume":"16","author":"L He","year":"2022","unstructured":"He L, Yu X, Li W. Recent progress and trends in X-ray-induced photodynamic therapy with low radiation doses. ACS Nano. 2022;16(12):19691\u2013721.","journal-title":"ACS Nano"},{"issue":"1","key":"4027_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","volume":"23","author":"M Li","year":"2025","unstructured":"Li M, Lu L, Bao Q, Zhou M, Nie B, Liu Y, et al. Radiotherapy\u2011derived engineered stem cell exosomes improve anti\u2011glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon. J Nanobiotechnol. 2025;23(1):239.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4027_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12951-024-02727-7","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Ji DK, Huang Y, Huang W, Dong X, et al. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer. J Nanobiotechnol. 2024;22(1):461.","journal-title":"J Nanobiotechnol"},{"key":"4027_CR10","doi-asserted-by":"publisher","DOI":"10.34133\/research.0429","volume":"7","author":"L Zhao","year":"2024","unstructured":"Zhao L, Li M, Shen C, Luo Y, Hou X, Qi Y, et al. Nano-assisted radiotherapy strategies: new opportunities for treatment of non-small cell lung cancer. Research. 2024;7:0429.","journal-title":"Research"},{"issue":"10","key":"4027_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202105783","volume":"34","author":"J Yan","year":"2022","unstructured":"Yan J, Wang G, Xie L, Tian H, Li J, Li B, et al. Engineering radiosensitizer-based metal-phenolic networks potentiate STING pathway activation for advanced radiotherapy. Adv Mater. 2022;34(10):2105783.","journal-title":"Adv Mater"},{"issue":"50","key":"4027_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404605","volume":"36","author":"NM Carigga Gutierrez","year":"2024","unstructured":"Carigga Gutierrez NM, Clainche TL, Bulin AL, Leo S, Kadri M, Abdelhamid AGA, et al. Engineering radiocatalytic nanoliposomes with hydrophobic gold nanoclusters for radiotherapy enhancement. Adv Mater. 2024;36(50):2404605.","journal-title":"Adv Mater"},{"issue":"24","key":"4027_CR13","doi-asserted-by":"publisher","first-page":"25147","DOI":"10.1021\/acsnano.3c08068","volume":"17","author":"J Li","year":"2023","unstructured":"Li J, Lv Z, Guo Y, Fang J, Wang A, Feng Y, et al. Hafnium (Hf)-chelating porphyrin-decorated gold nanosensitizers for enhanced radio\u2013radiodynamic therapy of colon carcinomas. ACS Nano. 2023;17(24):25147\u201356.","journal-title":"ACS Nano"},{"issue":"1","key":"4027_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03530-8","volume":"23","author":"Y Huang","year":"2025","unstructured":"Huang Y, Lu Z, Liu H, Yang N, Chen Y, Wang C, et al. Human serum albumin-based KBiF4@HSA nanoclusters for dual-energy computed tomography and glutathione-scavenging radiotherapy of breast cancer. J Nanobiotechnol. 2025;23(1):451.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"4027_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.7150\/thno.124034","volume":"16","author":"B Zeng","year":"2026","unstructured":"Zeng B, Ling K, Yuan Q, Chen Z, Zhang G, Kang W, et al. An organolutetium nanosensitizer synergizes with PARP inhibition to unleash STING-mediated immunity for low-dose radioimmunotherapy. Theranostics. 2026;16(4):1720\u201339.","journal-title":"Theranostics"},{"key":"4027_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100952","volume":"35","author":"P Lei","year":"2020","unstructured":"Lei P, Feng J, Zhang H. Emerging biomaterials: taking full advantage of the intrinsic properties of rare earth elements. Nano Today. 2020;35:100952.","journal-title":"Nano Today"},{"issue":"1","key":"4027_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-018-0140-z","volume":"22","author":"R Baskaran","year":"2018","unstructured":"Baskaran R, Lee J, Yang SG. Clinical development of photodynamic agents and therapeutic applications. Biomater Res. 2018;22(1):25.","journal-title":"Biomater Res"},{"key":"4027_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114622","volume":"216","author":"H Jiang","year":"2022","unstructured":"Jiang H, Xia Q, Zheng J, Bu J, Li R, Cai Z, et al. Mn2+ modified black phosphorus nanosheets with enhanced DNA adsorption and affinity for robust sensing. Biosens Bioelectron. 2022;216:114622.","journal-title":"Biosens Bioelectron"},{"issue":"4","key":"4027_CR19","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1021\/acsnano.3c07123","volume":"18","author":"K Ling","year":"2024","unstructured":"Ling K, Zheng J, Jiang X, Huang W, Mai Y, Liao C, et al. Mn2+\/CpG oligodeoxynucleotides codecorated black phosphorus nanosheet platform for enhanced antitumor potency in multimodal therapy. ACS Nano. 2024;18(4):2841\u201360.","journal-title":"ACS Nano"},{"issue":"2","key":"4027_CR20","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1021\/acsnano.0c09454","volume":"15","author":"L Chan","year":"2021","unstructured":"Chan L, Chen X, Gao P, Xie J, Zhang Z, Zhao J, et al. Coordination-driven enhancement of radiosensitization by black phosphorus via regulating tumor metabolism. ACS Nano. 2021;15(2):3047\u201360.","journal-title":"ACS Nano"},{"key":"4027_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jconrel.2014.12.027","volume":"200","author":"X Ma","year":"2015","unstructured":"Ma X, Huang X, Moore Z, Huang G, Kilgore JA, Wang Y, et al. Esterase-activatable \u03b2-lapachone prodrug micelles for NQO1-targeted lung cancer therapy. J Control Release. 2015;200:201\u201311.","journal-title":"J Control Release"},{"issue":"20","key":"4027_CR22","doi-asserted-by":"publisher","first-page":"2300349","DOI":"10.1002\/adhm.202300349","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Feng M, Guo T, Wang Z, Zhao Y. Tailored Beta-Lapachone Nanomedicines for Cancer-Specific Therapy. Adv Healthc Mater. 2023;12(20):2300349.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"4027_CR23","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ccell.2016.11.006","volume":"30","author":"X Huang","year":"2016","unstructured":"Huang X, Motea EA, Moore ZR, Yao J, Dong Y, Chakrabarti G, et al. Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors. Cancer Cell. 2016;30(6):940\u201352.","journal-title":"Cancer Cell"},{"key":"4027_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216507","volume":"582","author":"G Chen","year":"2024","unstructured":"Chen G, Zheng D, Zhou Y, Du S, Zeng Z. Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma. Cancer Lett. 2024;582:216507.","journal-title":"Cancer Lett"},{"issue":"1","key":"4027_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01960-w","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Tang X, Zhao M, Zhang Y, Xiao Y, Liu Y. Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo\/radiotherapy of glioblastoma. J Nanobiotechnol. 2023;21(1):210.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4027_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50688-0","volume":"15","author":"R Yue","year":"2024","unstructured":"Yue R, Li Z, Liu H, Wang Y, Li Y, Yin R, et al. Imaging-guided companion diagnostics in radiotherapy by monitoring APE1 activity with afterglow and MRI imaging. Nat Commun. 2024;15(1):6349.","journal-title":"Nat Commun"},{"issue":"8","key":"4027_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102298","volume":"11","author":"L Song","year":"2022","unstructured":"Song L, Chen B, Qin Z, Liu X, Guo Z, Lou H, et al. Temperature-dependent CAT-like RGD-BPNS@SMFN nanoplatform for PTT-PDT self-synergetic tumor phototherapy. Adv Healthc Mater. 2022;11(8):2102298.","journal-title":"Adv Healthc Mater"},{"issue":"13","key":"4027_CR28","doi-asserted-by":"publisher","first-page":"19382","DOI":"10.1021\/acsami.4c22168","volume":"17","author":"K Ling","year":"2025","unstructured":"Ling K, Bu J, Huang W, Kang W, Yuan Q, Zeng B, et al. Robust Cu2+-modified black phosphorus nanoplatform for enhanced drug delivery and synergistic multimodal tumor therapy via metal ion-assisted \u03c0\u2013\u03c0 interactions. ACS Appl Mater Interfaces. 2025;17(13):19382\u2013400.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"4027_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.chempr.2021.11.022","volume":"8","author":"L Zeng","year":"2022","unstructured":"Zeng L, Zhang X, Liu Y, Yang X, Wang J, Liu Q, et al. Surface and interface control of black phosphorus. Chem. 2022;8(3):632\u201362.","journal-title":"Chem"},{"issue":"1","key":"4027_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02659-2","volume":"22","author":"S Su","year":"2024","unstructured":"Su S, Liu L, Fu Q, Ma M, Yang N, Pan T, et al. A black phosphorus nanosheet-based RNA delivery system for prostate cancer therapy by increasing the expression level of tumor suppressor gene PTEN via CeRNA mechanism. J Nanobiotechnol. 2024;22(1):391.","journal-title":"J Nanobiotechnol"},{"issue":"32","key":"4027_CR31","doi-asserted-by":"publisher","first-page":"29160","DOI":"10.1021\/acsnano.5c02886","volume":"19","author":"M Hullo","year":"2025","unstructured":"Hullo M, Fonknechten N, Lacrouts C, Piton G, Noireaux J, Chevillard S, et al. The uptake of metallic nanoparticles in breast cancer cell lines is modulated by the hyaluronan-CD44 axis. ACS Nano. 2025;19(32):29160\u201380.","journal-title":"ACS Nano"},{"key":"4027_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123062","volume":"317","author":"Y Xiong","year":"2025","unstructured":"Xiong Y, He C, Qi J, Xiong M, Liu S, Zhao J. Biomaterials black phosphorus nanosheets activate tumor immunity of glioblastoma by modulating the expression of the immunosuppressive molecule PD-L1. Biomaterials. 2025;317:123062.","journal-title":"Biomaterials"},{"issue":"10","key":"4027_CR33","doi-asserted-by":"publisher","first-page":"1800510","DOI":"10.1002\/advs.201800510","volume":"5","author":"X Zeng","year":"2018","unstructured":"Zeng X, Luo M, Liu G, Wang X, Tao W, Lin Y, et al. Polydopamine-Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments. Adv Sci. 2018;5(10):1800510.","journal-title":"Adv Sci"},{"issue":"1","key":"4027_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16513-0","volume":"11","author":"K Hu","year":"2020","unstructured":"Hu K, Xie L, Zhang Y, Hanyu M, Yang Z, Nagatsu K, et al. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy. Nat Commun. 2020;11(1):2781.","journal-title":"Nat Commun"},{"issue":"5","key":"4027_CR35","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1021\/acsami.5b10056","volume":"8","author":"B Ghaemi","year":"2016","unstructured":"Ghaemi B, Mashinchian O, Mousavi T, Karimi R, Kharrazi S, Amani A. Harnessing the cancer radiation therapy by lanthanide-doped Zinc oxide based theranostic nanoparticles. ACS. ACS Appl Mater Interfaces. 2016;8(5):3123\u201334.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"18","key":"4027_CR36","doi-asserted-by":"publisher","first-page":"8708","DOI":"10.1039\/D4NR00284A","volume":"16","author":"Z Zhong","year":"2024","unstructured":"Zhong Z, Deng W, Wu J, Shang H, Tong Y, He Y, et al. Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy. Nanoscale. 2024;16(18):8708\u201338.","journal-title":"Nanoscale"},{"issue":"24","key":"4027_CR37","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1158\/0008-5472.CAN-24-0800","volume":"84","author":"M Luo","year":"2024","unstructured":"Luo M, Shen N, Shang L, Fang Z, Xin Y, Ma Y, et al. Simultaneous targeting of NQO1 and SOD1 eradicates breast cancer stem cells via mitochondrial futile redox cycling. Cancer Res. 2024;84(24):4264\u201382.","journal-title":"Cancer Res"},{"issue":"20","key":"4027_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400514","volume":"13","author":"Y Ma","year":"2024","unstructured":"Ma Y, Yi J, Ruan J, Ma J, Yang Q, Zhang K, et al. Engineered cell membrane-coated nanoparticles: new strategies in glioma targeted therapy and immune modulation. Adv Healthc Mater. 2024;13(20):2400514.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4027_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01324-8","volume":"8","author":"X Peng","year":"2023","unstructured":"Peng X, Wang Y, Zhang S, Tao Z, Dai Y, Claret FX, et al. Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair. Signal Transduct Target Ther. 2023;8(1):119.","journal-title":"Signal Transduct Target Ther"},{"key":"4027_CR40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jconrel.2024.03.019","volume":"368","author":"A Nomani","year":"2024","unstructured":"Nomani A, Yousefi S, Sargsyan D, Hatefi A. A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors. J Control Release. 2024;368:728\u201339.","journal-title":"J Control Release"},{"issue":"3","key":"4027_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","volume":"2","author":"H Cabral","year":"2024","unstructured":"Cabral H, Li J, Miyata K, Kataoka K. Controlling the biodistribution and clearance of nanomedicines. Nat Rev Bioeng. 2024;2(3):214\u201332.","journal-title":"Nat Rev Bioeng"},{"issue":"18","key":"4027_CR42","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1039\/D3MA00231D","volume":"4","author":"I Mutreja","year":"2023","unstructured":"Mutreja I, Maalej N, Kaushik A, Kumar D, Raja A. High atomic number nanoparticles to enhance spectral CT imaging aspects. Mater Adv. 2023;4(18):3967\u201388.","journal-title":"Mater Adv"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04027-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:07:58Z","timestamp":1770772078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4027"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04027-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed under protocols approved by the Institutional Animal Care and Use Committee of Shantou University Medical College (approval number: SUMC2023-044) and followed institutional ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}